We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Immunoassay Determines Thiopurine Methlytransferase Activity in Erythrocytes

By LabMedica International staff writers
Posted on 08 Sep 2008
A new TPMT activity assay is a competitive microwell immunoassay for the semi-quantitative determination of thiopurine methlytransferase (TPMT) activity in erythrocytes. More...


The level of patient TPMT activity is the best indicator for an individual patient's ability to metabolize specific medicines, avoid toxicities, and their individual therapeutic efficacy. These drugs are typically used for the treatment of inflammatory bowel diseases (IBDs), leukemia, and many other medical disorders.

TPMT catalyzes the S-methylation of 6-mercaptopurine (6-MP) with the presence of S-adenosylmethionine (SAM), the methyl donor, yielding 6-methylmercaptopurine (6-MMP). 6-MMP, a small molecule, is then measured with a microwell enzyme immunoassay (EIA).

The successful development of specific antibodies against 6-MMP and the introduction of the harsh methylation reaction product mix into the delicate immunoassay environment mark a technologic breakthrough. This new assay system brings clinicians and patients tremendous benefits in the area of clinical pharmacogenomics.

Biologix Diagnostics, LLC (Lenexa, KS, USA) announced that its new technology is now available for sale worldwide.

Related Links:
Biologix Diagnostics


Gold Member
H-FABP Assay
Heart-Type Fatty Acid-Binding Protein Assay
Online QC Software
Acusera 24•7
Electrolyte Analyzer
BKE-B
New
Gold Member
Pre- Eclampsia Control
Acusera Pre-Eclampsia Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Graphical Abstract (Morgane Fournier et al., Cell (2026). DOI: 10.1016/j.cell.2026.04.013)

Study Reveals Immune Mechanism Driving Severe COVID-19 Progression

Severe COVID-19 has highlighted gaps in understanding of early antiviral responses, particularly why some patients deteriorate despite timely care. Type I interferons are central to host defense, yet their... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.